ArticleCEN case reports2025

Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series.

Junji Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.